The effects of autonomic substances and 5-hydroxytryptamine (serotonin) upon the smooth muscle of the intestine are not completely understood despite extensive experimentation in vitro and in vivo. Serotonin may play an important role in the normal regulation of intestinal motility, since, in vitro, it causes strong contraction of intestinal smooth muscle (1, 2) ; when given intravenously both to man and certain experimental animals, it stimulates intestinal motility (3) (4) (5) ;
and its excess production is associated with diarrhea and increased peristalsis in the metastatic carcinoid syndrome (6, 7) . The major body depot of serotonin is the gastrointestinal tract where it is localized in the enterochromaffin cells of the mucosa. Its mechanism of action upon the intestine is unclear, and there are many conflicting reports on its relationship to the autonomic nervous system (1) (2) (3) (4) (5) (8) (9) (10) .
In order more closely to ascertain the effect of acetylcholine, methacholine and serotonin upon mammalian intestinal smooth muscle, an in vivo experimental technique has been devised. This method, which is easy to perform and yields reproducible results, makes it possible to introduce the test substances directly and initially into the intact intestine. This is accomplished by injections into the terminal or end artery, which nourishes a segment of proximal colon, of an anesthetized dog. be stabilized by exerting tension prior to each injection. All injections were made with a 1 ml. syringe and a 27 gauge needle (Figure 1 ). Injections were noted on the recording drum by means of an electric signal marker or manual compression of the rubber tubing leading from the manometer. Unless otherwise specified, all test substances 2 were injected in volumes of 0.1 ml. 2 Great care was exercised during the preparation of the di-isopropylfluorophosphate (DFP) solution. 4 The material was always handled under a hood, the experimenter's arms extending through aperatures in its window. One-tenth gram DFP (0.1 ml.) was carefully withdrawn from the stock container, placed in a 100 ml. volumetric flask, and diluted with buffered Locke's solution, yielding a final concentration of 1.0 mg. per ml. The container was then carefully sealed and immersed in a metal can of sodium bicarbonate. All DFP injections were given within one-half hour of preparation.
Cholinesterase determinations were performed on segments of colon in a number of experiments. Since the test segment of colon could not be used as its own control for cholinesterase content, a segment distal to it was also removed at the end of some experiments in which DFP had been given. Cholinesterase values for these two sections of colon were comparable under normal circumstances. Determinations of tissue cholinesterase in these segments were performed by the Warburg manometric technique with acetylcholine as substrate (11 parative effect of marked lowering of colon cholinesterase (75 to 95 per cent) upon the action of serotonin and acetylcholine was studied in two animals (Nos. 47, 49). The threshold for acetylcholine decreased in one animal, but was unchanged for serotonin. Further, although serotonin response was augmented, the degree of augmentation was less than that for acetylcholine ( Figure 6 ) and may represent an addition of effect of this agent combined with endogenous acetylcholine.
Combined action of serotonin and acetylcholine
To ascertain whether serotonin and acetylcholine enhance each other's action, we compared the effects of a mixture of half of the volume of an approximately equi-effective dose of each agent, with that of each reference dose. In no case of such combined administration did augmentation occur. In 11 of 14 observations the effects were only additive. In three trials, moreover, the response to the combination was less than that of either reference dose (Figure 7 ). In 25 dogs there was no alteration of response to acetylcholine administered from five seconds to 60 minutes after serotonin.
Effect of an anticholinergic drug
The effect of an anticholinergic agent, atropine, upon the action of serotonin was observed in eight animals. Figure 8 shows the effect of 1.0 mg. of this substance on the subsequent injections of serotonin and acetylcholine. Although the threshold for acetylcholine was increased 100-fold, the serotonin threshold was unaffected and indeed in several experiments there appeared to be augmentation (Figure 8 ). Higher doses cf atropine, 6 to 8 mg., raised the serotonin threshold 10-to 20-fold, while changing that for acetylcholine 1,000-to 5,000-fold. Even after 85 per cent inhibition of cholinesterase, the relative effectiveness of a large dose of atropine upon serotonin and acetylcholine was unchanged ( Figure 9 ).
Ganglion blockade
Hexamethonium, 1.5 to 12.5 mg., did not block the action of either serotonin or acetylcholine; indeed, in three of four observations, it seemed to augment the serotonin response ( Figure 10 ).
Monoamine oxidase inhibition U-7729,5 a methyl analog of serotonin and monoamine oxidase inhibitor (MOI), was administered in doses of 100 jug. on nine occasions in four animals. On eight occasions it produced contraction of the bowel and it augmented the response of serotonin in five of nine instances and of acetylcholine on seven of nine occasions (Figure 11) . In a fifth dog, no spontaneous response to the same dose of MOI was noted, although serotonin and acetylcholine contractions were augmented. Despite a total dose of 400 jug. MOI in each of four experiments, there was no alteration in the threshold dose for either drug.
Further, administration of MOI only slightly altered the relative effect of atropine upon serotonin and acetylcholine; i.e., the ratio of atropine inhibition of these agents (acetylcholine/serotonin) was between 10/1 and 100/1 ( Figure 12 there was a 10-fold increase in serotonin threshold ( Figure 14) ; after 4.0 mg., a 100-fold increase, the duration of inhibitory effect averaging about 30 minutes. When 100 mg. of BAS was given intravenously on two occasions, there occurred a 10-fold increase in threshold in one animal, but threshold was unaffected in the other. Neither prochlorperazine nor BAS changed the intestinal response to acetylcholine.
DISCUSSION
These studies on the effect of acetylcholine, methacholine and serotonin on the dog colon have demonstrated the advantages and usefulness of an in vivo intra-arterial injection technique. The procedure is simple, yields reproducible results and is stable enough to permit experimentation over an eight to 10 hour period. In addition, it permits recording intestinal action in a preparation that has an intact innervation and blood supply.
The contractile effect of acetylcholine and methacholine on the intestine is well known (12- 14). In our stullies the range of threshold dose of these two drugs was similar and approximates that derived from perfusion experiments (15); however, when these drugs are given intravenously, the average threshold dose range is about 1,000-fold greater (11) .
Of interest is the finding that the characteristic responses to both these agents differ, the acetylcholine response being more rapid in onset and decline and the methacholine response lasting longer. The explanation of the longer methacholine response may be its slower hydrolysis by the tissue cholinesterase. The individual responses to each of these agents were reproducible over a period of eight to 10 hours, there being no tachyphylaxis or change in threshold dosage.
Study of the effect of acutely reducing the tissue cholinesterase upon the action of these agents through intra-arterial injection of DFP is limited by the reaction of the effector organ to large amounts of the anticholinesterase compound. fold) alteration in threshold dosage seems surprising. However, Riker and Wescoe reported similar results in their experiments (16) . Using DFP, they found that suppression of cholinesterase by at least 50 per cent was required to reduce threshold stimulus (frequency of electric shocks to the chorda tympani) and that the maximal alteration in threshold occurred only at 90 per cent suppression. When they administered supramaximal stimuli, the total response (volume of saliva) increased when cholinesterase was reduced 50 to 90 per cent; this increase was manifested principally as a prolongation of response after stimulation; the response during stimulation was altered slightly. These findings indicate that tissue cholinesterase occurs in a concentration which is far in excess of what is required for normal function.
These results in another parasympathetic-effector system are strikingly similar to those of the intestine. In the latter there was little change of threshold stimulus despite marked reduction in tissue cholinesterase and, analagous to the increased post-stimulus salivation for the submaxillary gland, there was prolongation of contraction in the intubated segment of the intestine ( Figure  5 ). Further, Riker and Wescoe obtained the same relationship after DFP when the salivary gland was stimulated with intra-arterial injection of acetylcholine instead of by electrical shocking. These authors suggest that this augmented response is due to prolonged action of acetylcholine (or methacholine) at the myoneural junctions.
Serotonin appears to be as potent as acetylcholine in its contractile effect upon the intestinal musculature, the average threshold dose for each substance being the same and the magnitude and duration of response being comparable. There was no evidence for mutual potentiation with acetylcholine; mixtures of the two substances were at most only additive. Although the in vitro studies of Pick (9) , using guinea pig ileum, suggested that serotonin enhanced the action of acetylcholine and related compounds, this finding is not confirmed by our work nor by that of Freyburger and associates (5) . That serotonin acts via a cholinergic pathway or mechanism seems unlikely for several reasons. First, although colon cholinesterase depression by 80 per cent or greater was associated with augmented response to both serotonin and acetylcholine, potentiation occurred only for the latter substance. Second, atropine was 100 times more potent in blocking acetylcholine than serotonin. Indeed, with lower doses of atropine, 1.0 mg. or less, serotonin response appeared to be augmented. Garven (18) , using guinea pig ileum, showed that atropine had this same ratio of potency for inhibiting these two agents. Likewise, Gaddum and Hameed (1) found it only partially effective against the action of serotonin on the guinea pig ileum. However, Rocha e Silva, Valle and Picarelli (2), using a similar preparation, demonstrated that atropine was a potent inhibitor of both serotonin and acetylcholine. While Hendrix, Atkinson, Clifton and Ingelfinger (3) observed that atropine inhibited the action of serotonin upon the small intestine in man, Haverback and Davidson (4) could not confirm this finding. Since in both these experiments all substances were given intravenously, comparison with the in vitro and intra-arterial techniques is difficult.
That serotonin does not act via the autonomic ganglia is demonstrated by the failure of hexamethonium to block its response; indeed, an opposite effect may occur, since there was an augmented serotonin response in three of four instances in which it was given after hexamethonium. The reason for this augmentation, also suggested by Rocha e Silva and associates in their studies upon the guinea pig ileum (2) , is unclear. It may be related to increased excitability of muscle fibers following ganglionic blockade, as was suggested by Feldberg (19) . Possibly, large doses of methonium compounds stimulate the postsynaptic cells of the ganglia (20) .
A striking observation in the experiments with hexamethonium was the failure of this agent, even in large dosage, to diminish the usual response to acetylcholine. Such diminution might have been expected since part of the action of acetylcholine upon smooth muscle of the intestine is mediated via the ganglion cells of the myenteric plexuses, and a large dose of hexamethonium may block acetylcholine at the neuroeffector junction (21) . Perhaps a partial explanation, as suggested by Riker and Szreniawski (22) , is that the predominant site for inhibition of acetylcholine by hexamethonium in the ganglion is not at the postsynaptic levels, but rather at the terminals of the presynaptic fibers.
Prochlorperazine and BAS completely block the spasmogenic action of serotonin upon the intestine and do not alter the acetylcholine response. This inhibitory effect of a phenothiazine has also been shown upon the rat colon, in vitro, by Benditt and Rowley (23) . Such behavior might be expected, since the structure of serotonin is similar to epinephrine and norepinephrine, all three substances being destroyed by monoamine oxidase, and the phenothiazines possess sympatholytic properties (24) . BAS probably exerts its effects by means of a specific competition with serotonin (25) .
Monoamine oxidase, which exists in high concentration in the intestine (26) , plays an important role in the metabolism of serotonin. Inhibition of this enzyme augments serotonin response. The kinetics of this interaction may be analogous to that for acetylcholine and cholinesterase, since inhibition of cholinesterase is associated with an augmentation of acetylcholine effect. This interaction of serotonin and monoamine oxidase, which probably occurs at a significant rate in the intestine, may further indicate that serotonin plays a role in the regulation of motility of this organ.
Although it seems clear from these studies that exogenously administered serotonin does not act by way of a cholinergic pathway in the intact animal, it has been amply established by Bulbring and Lin (27) that this agent acts as a modulator of the cholinergic system by reducing the threshold of the presso-receptors in the gut wall. Possibly, a ganglionic blocking effect of serotonin in our intact preparation may have prevented its potentiation of acetylcholine at the neuroeffector site (28) . SUMMARY 1. An in vivo intra-arterial injection technique for the study of the effect of drugs upon the smooth muscle of the dog colon is described. Using this technique, the threshold dosage for acetylcholine and methacholine has ranged from 0.001 to 0.1 ug, and 0.001 to 1.0 pg., respectively.
2. Utilizing di-isopropylfluorophosphate, acute reduction of bowel cholinesterase (43 to 97 per cent) was achieved. This alteration was associated uniformly with augmentation of response to both acetylcholine and methacholine; however, at least 80 per cent inhibition was necessary to alter the threshold dose.
3. The action of 5-hydroxytryptamine (serotonin) and acetylcholine upon the colon of intact, anesthetized dogs was compared. The average threshold dose to induce contraction was the same for each substance.
4. Atropine was ineffective in blocking serotonin response as compared with acetylcholine, and inhibition of tissue cholinesterase failed to potentiate serotonin effect.
5. Although hexamethonium blocked neither acetylcholine nor serotonin response, mediation of action of these substances via autonomic ganglia is not excluded, since hexamethonium may act at the presynaptic level.
6. Effect of serotonin was enhanced by inhibition of monoamine oxidase and was blocked by both its benzyl analog and a phenothiazine derivative, prochlorperazine.
7. These results suggest that when serotonin is administered intra-arterially to an intact colon, it does not act via a cholinergic pathway; however, they do not negate previous evidence that this substance may be a modulator of the cholinergic system.
